Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kraig Biocraft LaboratoriesKBLB -0.30% Receivables Turnover is 0.00 as of Mar. 2026. The stock has 2 warning signs investors should review. Among 1,577 Chemicals companies, Kraig Biocraft Laboratories ranks worse than 63411.48% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Kraig Biocraft Laboratories's Revenue for the
three
months ended in Mar. 2026 was $0.00 Mil. Kraig Biocraft Laboratories's average Accounts Receivable for the
three
months ended in Mar. 2026 was $0.00 Mil.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Kraig Biocraft Laboratories Receivables Turnover Related Terms
Kraig Biocraft Laboratories Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KBLB vs AMTX, FSI, NTIC: Receivables Turnover Comparison
For the Specialty Chemicals subindustry, Kraig Biocraft Laboratories's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kraig Biocraft Laboratories Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Kraig Biocraft Laboratories's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Kraig Biocraft Laboratories's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kraig Biocraft Laboratories (KBLB) has a Receivables Turnover of 0.00 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Kraig Biocraft Laboratories and its competitors. According to the industry distribution chart, Kraig Biocraft Laboratories ranks #999999 out of 1577 companies in the Chemicals industry.
Is Kraig Biocraft Laboratories' Receivables Turnover too high?
Kraig Biocraft Laboratories' current Receivables Turnover is 0.00. Based on the distribution chart, Kraig Biocraft Laboratories ranks #999999 out of 1577 companies in the Chemicals industry, which is in the bottom quartile relative to peers.
How does Kraig Biocraft Laboratories' Receivables Turnover compare to AMTX and FSI?
According to the Chemicals industry distribution chart, Kraig Biocraft Laboratories ranks #999999 out of 1577 companies for Receivables Turnover. This places Kraig Biocraft Laboratories in the lower half of its industry. The industry median Receivables Turnover is 5.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.60, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Kraig Biocraft Laboratories and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kraig Biocraft Laboratories's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kraig Biocraft Laboratories stock overvalued right now?
Kraig Biocraft Laboratories (KBLB) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Kraig Biocraft Laboratories (KBLB), the current Receivables Turnover is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fiber using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; Dragon Silk, which combines the elasticity of Monster Silk with additional high-strength elements of native spider silk; Spydasilk; and Spydra.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KBLB has been successfully added to your 
